Black holes with ravenous appetites

Artist’s concept of an active galaxy – with a supermassive black hole at its core, surrounded by a large, dark, donut-shaped cloud of gas and dust. Differences in Type I and Type II active galaxies were thought to be due to differences in the orientation of this cloud with respect to Earth. But a new study suggests otherwise. Image via NASA/JPL-Caltech.

An international team of astronomers released results today (September 27, 2017) of a new X-ray study of active galaxies, which are those having a compact, highly luminous core in an otherwise normal-looking galaxy. The new study contradicts a decades-old, popular theory – the unified model of active galaxies – and provides a new answer to the question of why Type I active galaxies appear brighter than Type IIs. Both Type Is and Type IIs are thought to have supermassive black holes at their cores. The older unified model suggested Type Is appear brighter from Earth because they’re oriented differently. The new study suggests fundamental physical differences in the way Type Is consume matter and spit out energy. Specifically, it suggests, Type Is are more efficient eaters.

The results will be published September 28 in the peer-reviewed journal Nature. Richard Mushotzky, a professor of astronomy at University of Maryland and a co-author of the study, said in a statement:

The unified model has been the prevailing wisdom for years. However, this idea does not fully explain the differences we observe in galaxies’ spectral fingerprints, and many have searched for an additional parameter that fills in the gaps.

Our new analysis of X-ray data from NASA’s Swift Burst Alert Telescope suggests that Type I galaxies are much more efficient at emitting energy.

To conduct the study, Mushotzky and his colleagues re-examined data from 836 active galaxies detected by NASA’s Swift Burst Alert Telescope that strongly emit high-energy, or “hard,” X-rays — the same X-rays that medical technicians use to visualize the human skeleton.

To measure the mass and growth rate of these galaxies’ active nuclei — the supermassive black holes at the galaxies’ centers — the researchers used data from 12 different ground-based telescopes spread across the globe to complement the data from the Swift satellite. Michael Koss, a research scientist at Eureka Scientific, Inc. and a co-author of the paper, said:

This project began in 2009, as part of my doctoral work at UMD, and has radically grown with the help of more than 40 researchers across the globe. When I started out, I spent a month of lonely nights by myself at the Kitt Peak National Observatory observing a few dozen galaxies. I never dreamed we would eventually expand to such a large sample, enabling us to answer many amazing scientific questions for the first time.

The researchers said that – when they compared differences in the X-ray spectra between Type I and Type II galaxies – they found that, regardless of which way the galaxy faces Earth, the central black holes in Type I galaxies consume matter and emit energy much faster compared with the black holes at the center of Type II galaxies. Mushotzky said:

Our results suggest this has a lot to do with the amount of dust that sits close to the central black hole. Type II galaxies have a lot more dust close to the black hole, and this dust pushes against the gas as it enters the black hole.

The astronomers commented that, for decades, astronomers have preferentially studied Type II galaxies. That’s largely because the active nuclei of Type I galaxies are very bright, making it difficult to see the stars and gas clouds that constitute the rest of the galaxy and because, after all, the unified model had suggested that all active galaxies were fundamentally the same. Mushotzky said:

But now, because our results suggest that the two types of galaxies are indeed fundamentally different, it is likely that a lot of researchers will re-evaluate their data and take another look at Type I galaxies. By putting us on a path to better understand the differences between the galaxies that host Type I and Type II active nuclei, this work will help us better understand how supermassive black holes influence the evolution of their host galaxies.

Bottom line: New work suggests fundamental differences in Type I and Type II galaxies, contradicting a long-established theory.



from EarthSky http://ift.tt/2k0Xqgm

Artist’s concept of an active galaxy – with a supermassive black hole at its core, surrounded by a large, dark, donut-shaped cloud of gas and dust. Differences in Type I and Type II active galaxies were thought to be due to differences in the orientation of this cloud with respect to Earth. But a new study suggests otherwise. Image via NASA/JPL-Caltech.

An international team of astronomers released results today (September 27, 2017) of a new X-ray study of active galaxies, which are those having a compact, highly luminous core in an otherwise normal-looking galaxy. The new study contradicts a decades-old, popular theory – the unified model of active galaxies – and provides a new answer to the question of why Type I active galaxies appear brighter than Type IIs. Both Type Is and Type IIs are thought to have supermassive black holes at their cores. The older unified model suggested Type Is appear brighter from Earth because they’re oriented differently. The new study suggests fundamental physical differences in the way Type Is consume matter and spit out energy. Specifically, it suggests, Type Is are more efficient eaters.

The results will be published September 28 in the peer-reviewed journal Nature. Richard Mushotzky, a professor of astronomy at University of Maryland and a co-author of the study, said in a statement:

The unified model has been the prevailing wisdom for years. However, this idea does not fully explain the differences we observe in galaxies’ spectral fingerprints, and many have searched for an additional parameter that fills in the gaps.

Our new analysis of X-ray data from NASA’s Swift Burst Alert Telescope suggests that Type I galaxies are much more efficient at emitting energy.

To conduct the study, Mushotzky and his colleagues re-examined data from 836 active galaxies detected by NASA’s Swift Burst Alert Telescope that strongly emit high-energy, or “hard,” X-rays — the same X-rays that medical technicians use to visualize the human skeleton.

To measure the mass and growth rate of these galaxies’ active nuclei — the supermassive black holes at the galaxies’ centers — the researchers used data from 12 different ground-based telescopes spread across the globe to complement the data from the Swift satellite. Michael Koss, a research scientist at Eureka Scientific, Inc. and a co-author of the paper, said:

This project began in 2009, as part of my doctoral work at UMD, and has radically grown with the help of more than 40 researchers across the globe. When I started out, I spent a month of lonely nights by myself at the Kitt Peak National Observatory observing a few dozen galaxies. I never dreamed we would eventually expand to such a large sample, enabling us to answer many amazing scientific questions for the first time.

The researchers said that – when they compared differences in the X-ray spectra between Type I and Type II galaxies – they found that, regardless of which way the galaxy faces Earth, the central black holes in Type I galaxies consume matter and emit energy much faster compared with the black holes at the center of Type II galaxies. Mushotzky said:

Our results suggest this has a lot to do with the amount of dust that sits close to the central black hole. Type II galaxies have a lot more dust close to the black hole, and this dust pushes against the gas as it enters the black hole.

The astronomers commented that, for decades, astronomers have preferentially studied Type II galaxies. That’s largely because the active nuclei of Type I galaxies are very bright, making it difficult to see the stars and gas clouds that constitute the rest of the galaxy and because, after all, the unified model had suggested that all active galaxies were fundamentally the same. Mushotzky said:

But now, because our results suggest that the two types of galaxies are indeed fundamentally different, it is likely that a lot of researchers will re-evaluate their data and take another look at Type I galaxies. By putting us on a path to better understand the differences between the galaxies that host Type I and Type II active nuclei, this work will help us better understand how supermassive black holes influence the evolution of their host galaxies.

Bottom line: New work suggests fundamental differences in Type I and Type II galaxies, contradicting a long-established theory.



from EarthSky http://ift.tt/2k0Xqgm

Virtual Reality Helps Veterans Prepare For New Jobs

The U.S. Army Research Laboratory and its partners recently developed a new way for veterans to seek employment using virtual reality.

from http://ift.tt/2xBkh5B
The U.S. Army Research Laboratory and its partners recently developed a new way for veterans to seek employment using virtual reality.

from http://ift.tt/2xBkh5B

First quarter moon points to Saturn

Tonight – September 27, 2017 – as darkness falls around the world, the moon will be at or near its first quarter phase. The terminator line – or line between light and dark on the moon – will appear straight. What’s more, the illuminated side of this September moon points toward two bright “stars.” Only one is a true star, Antares in the constellation Scorpius. The other is the planet Saturn.

First quarter moon happens on September 28 at 2:54 UTC. At U.S. time zones, that places the date and time of the first quarter moon on September 27 at 10:54 p.m. EDT, 9:54 p.m. CDT, 8:54 p.m. MDT and 7:54 p.m. PDT.

By definition, and in the language of astronomy, the moon at its first quarter phase is at east quadrature – 90o east of the sun in geocentric ecliptic longitude. Technically speaking, the first quarter moon is not exactly 50% illuminated at east quadrature, although the lunar disk certainly looks half lit to the eye. Depending on the month, the illuminated portion of first quarter moon varies from 50.117% to 50.138%.

Karl Diefenderfer caught a first quarter moon at sunset on June 12, 2016.

A first quarter moon at sunset. “Such a lucky shot,” wrote photographer Karl Diefenderfer in Quakertown, Pennsylvania.

To be less ambiguous, we could say the moon at the instant that it lies 90o east of the sun is at east quadrature, rather than at first quarter. However, the term first quarter is synonymous with east quadrature, and the term last quarter moon is synonymous with west quadrature.

Not to scale! The illustration shows the moon at dichotomy as seen from Earth, and Earth at quadrature as seen from the moon. The moon resides at the vertex of the right angle. However, when it's the Earth that resides at the vertex of the right angle, then it's moon that's at quadrature as viewed from the Earth, and the Earth that's at dichotomy as seen from the moon.

Not to scale! The illustration shows the moon at dichotomy as seen from Earth, and Earth at quadrature as seen from the moon. The moon resides at the vertex of the right angle. However, when it’s the Earth that resides at the vertex of the right angle, then it’s moon that’s at quadrature as viewed from the Earth, and the Earth that’s at dichotomy as seen from the moon.

The moon is exactly half-illuminated at dichotomy, yet a tiny bit more than half-illuminated at quadrature (quarter moon). The moon always reaches dichotomy (50% illumination) a short while before its first quarter phase; and the moon always reaches its last quarter phase shortly before dichotomy. Depending on the month, the time period between dichotomy and quadrature can vary anywhere from about 15 to 21 minutes.

When the moon is at east quadrature (first quarter) in Earth’s sky, then it’s the Earth that’s at dichotomy in the moon’s sky – and vice versa.

Want more? See this cool diagram of dichotomy vs. quadrature via GeoGebra!

Bottom line: Tonight – September 27, 2017 – as darkness falls, enjoy the moon at or near its first quarter phase.



from EarthSky http://ift.tt/2fQHZTu

Tonight – September 27, 2017 – as darkness falls around the world, the moon will be at or near its first quarter phase. The terminator line – or line between light and dark on the moon – will appear straight. What’s more, the illuminated side of this September moon points toward two bright “stars.” Only one is a true star, Antares in the constellation Scorpius. The other is the planet Saturn.

First quarter moon happens on September 28 at 2:54 UTC. At U.S. time zones, that places the date and time of the first quarter moon on September 27 at 10:54 p.m. EDT, 9:54 p.m. CDT, 8:54 p.m. MDT and 7:54 p.m. PDT.

By definition, and in the language of astronomy, the moon at its first quarter phase is at east quadrature – 90o east of the sun in geocentric ecliptic longitude. Technically speaking, the first quarter moon is not exactly 50% illuminated at east quadrature, although the lunar disk certainly looks half lit to the eye. Depending on the month, the illuminated portion of first quarter moon varies from 50.117% to 50.138%.

Karl Diefenderfer caught a first quarter moon at sunset on June 12, 2016.

A first quarter moon at sunset. “Such a lucky shot,” wrote photographer Karl Diefenderfer in Quakertown, Pennsylvania.

To be less ambiguous, we could say the moon at the instant that it lies 90o east of the sun is at east quadrature, rather than at first quarter. However, the term first quarter is synonymous with east quadrature, and the term last quarter moon is synonymous with west quadrature.

Not to scale! The illustration shows the moon at dichotomy as seen from Earth, and Earth at quadrature as seen from the moon. The moon resides at the vertex of the right angle. However, when it's the Earth that resides at the vertex of the right angle, then it's moon that's at quadrature as viewed from the Earth, and the Earth that's at dichotomy as seen from the moon.

Not to scale! The illustration shows the moon at dichotomy as seen from Earth, and Earth at quadrature as seen from the moon. The moon resides at the vertex of the right angle. However, when it’s the Earth that resides at the vertex of the right angle, then it’s moon that’s at quadrature as viewed from the Earth, and the Earth that’s at dichotomy as seen from the moon.

The moon is exactly half-illuminated at dichotomy, yet a tiny bit more than half-illuminated at quadrature (quarter moon). The moon always reaches dichotomy (50% illumination) a short while before its first quarter phase; and the moon always reaches its last quarter phase shortly before dichotomy. Depending on the month, the time period between dichotomy and quadrature can vary anywhere from about 15 to 21 minutes.

When the moon is at east quadrature (first quarter) in Earth’s sky, then it’s the Earth that’s at dichotomy in the moon’s sky – and vice versa.

Want more? See this cool diagram of dichotomy vs. quadrature via GeoGebra!

Bottom line: Tonight – September 27, 2017 – as darkness falls, enjoy the moon at or near its first quarter phase.



from EarthSky http://ift.tt/2fQHZTu

Passing spacecraft snaps Earth’s pic

View larger. | Color composite image of Earth taken September 22 by the MapCam camera on NASA’s OSIRIS-REx spacecraftt, via NASA.

NASA released this new color composite image of Earth from space today (September 26, 2017). The OSIRIS-REx spacecraft – launched a year ago and bound for an encounter with asteroid Bennu in 2018 – acquired it during a close flyby of our planet on September 22. The spacecraft acquired this image just hours after it completed its Earth Gravity Assist at a range of approximately 106,000 miles (170,000 km). It used the MapCam camera on the craft, part of the OSIRIS-REx Camera Suite (OCAMS) operated by the University of Arizona.

The image spans the Pacific Ocean from Australia at the lower left, to Baja California and the southwestern United States in the upper right.

The dark vertical streaks at the top of the image are caused by short exposure times (less than three milliseconds), NASA said, adding:

Short exposure times are required for imaging an object as bright as Earth, but are not anticipated for an object as dark as the asteroid Bennu, which the camera was designed to image.

The OSIRIS-REx craft has the ultimate goal of obtaining a sample from asteroid Bennu and returning it to Earth in 2023.

Click here for more images from NASA’s OSIRIS-REx spacecraft.

Via NASA

Bottom line: Earth portrait from OSIRIS-REx asteroid craft, made from images acquired during the Earth gravity assist on September 22, 2017.



from EarthSky http://ift.tt/2xDStPm

View larger. | Color composite image of Earth taken September 22 by the MapCam camera on NASA’s OSIRIS-REx spacecraftt, via NASA.

NASA released this new color composite image of Earth from space today (September 26, 2017). The OSIRIS-REx spacecraft – launched a year ago and bound for an encounter with asteroid Bennu in 2018 – acquired it during a close flyby of our planet on September 22. The spacecraft acquired this image just hours after it completed its Earth Gravity Assist at a range of approximately 106,000 miles (170,000 km). It used the MapCam camera on the craft, part of the OSIRIS-REx Camera Suite (OCAMS) operated by the University of Arizona.

The image spans the Pacific Ocean from Australia at the lower left, to Baja California and the southwestern United States in the upper right.

The dark vertical streaks at the top of the image are caused by short exposure times (less than three milliseconds), NASA said, adding:

Short exposure times are required for imaging an object as bright as Earth, but are not anticipated for an object as dark as the asteroid Bennu, which the camera was designed to image.

The OSIRIS-REx craft has the ultimate goal of obtaining a sample from asteroid Bennu and returning it to Earth in 2023.

Click here for more images from NASA’s OSIRIS-REx spacecraft.

Via NASA

Bottom line: Earth portrait from OSIRIS-REx asteroid craft, made from images acquired during the Earth gravity assist on September 22, 2017.



from EarthSky http://ift.tt/2xDStPm

Taking part in clinical trials – Tommy’s story

Tommy Brennan, 65, is from Merseyside. He and his wife Barbara have two sons, and a three-year-old grandson, also called Tommy.

Here, Tommy senior tells his story of being diagnosed with cancer and joining a clinical trial, which he also shared as part of our Annual Review.

It was March 2012 when I first noticed some blood in my pee. I decided to go to the doctor the next day to get checked out. He did some tests and decided to send me to the hospital for a scan and a cystoscopy – that’s where they use a camera to look at your bladder. It sounds painful, but it’s actually not too bad. I’ve had around 16 of them now!

Even after being referred to the hospital I didn’t think it was anything serious. I thought it might be an infection or something. But unfortunately it wasn’t. The tests showed that I had a tumour in my bladder.

The first thing I thought was: ‘what’?! I was terrified to begin with, but then I decided I had to just get on with it.

My treatment involved chemotherapy as well as surgery to remove the tumour. But the cancer had spread into the muscle tissue, so it was worse than they first thought.

The doctor gave me two options. One was to have very complicated surgery to remove the whole of my bladder and reconstruct it from the bowel. I decided I definitely didn’t want that.

The other was to join a Cancer Research UK-funded clinical trial. Even though the doctor said I should take some time to think about it I decided within around 10 seconds that I wanted to join.

‘I was really well taken care of’

The trial was called TUXEDO and it involved having chemotherapy every week, along with radiotherapy 5 days a week for 7 weeks.

Being close to research made me realise just how much things have progressed.

Tommy Brennan

Before I joined I was told about the long list of possible side effects. That made me panic a little and I was a bit nervous. But I was lucky enough not to experience any of them.

I did put on a bit of weight in the beginning because I was taking steroids, but thankfully I didn’t have to take these for too long.

I was really well taken care of when I was on the trial. All the staff at the hospital were brilliant – from the receptionists through to the nurses, radiologists and doctors. Everyone was fantastic.

On top of that, the clinical trial nurses were really knowledgeable and reassuring, and they put me completely at ease. Without them and my consultant, Dr Hussain, I don’t know where I’d be.

When I finished having my treatment on the trial I had to wait about 3 months before the doctors could tell me whether it had worked.

It was April 2013 when Dr Hussain told me the good news that the treatment had been successful and that my cancer was gone.

I was over the moon.

‘Without clinical trials things would just stand still’

I have to admit that when I joined the trial I was thinking more about myself than anything else. But now I look back and I’m so glad I did something that could potentially help others in the future. And that could help science and cancer medicine move forward.

I knew nothing about clinical trials before I joined one. Now I realise how important they are. They’re needed to test new treatments, new drugs and new drug combinations. Without them we wouldn’t be able to make any progress; things would just stand still.

Being close to research made me realise just how much things have progressed. The advances in technology have been amazing and mean that even though I’ve been in an operating theatre 4 times, there’s not a scar on my body to show for it.

I know it’s not the same for everyone and some people do have scars after surgery. But in my case I’m lucky enough to not have any visible signs of the operations I’ve had.

Five years after his cancer diagnosis, Tommy is doing well.

I got a lot out of being on a clinical trial. Obviously there’s the fact that the treatment worked and my bladder didn’t have to be removed, which was great.

But on top of this, one of the main things I got out of being on the trial was the courage to be more open, and to talk about my cancer experience.

When I was diagnosed, I didn’t want every Tom, Dick and Harry knowing my business so I didn’t talk about it.

But a few months after my diagnosis the local radio station asked me to talk about my experience of being on a trial. And the local newspaper asked me to share my story too.

I decided to do them both.

I changed my mind because I know some people shy away from joining clinical trials and I wanted them to know it can be a really positive thing to take part in one. And I wanted people to know that joining a trial has the potential to help you right away, and many more people in the future.

‘If it wasn’t for research, I might not have got to see my grandson’

I’m delighted to say that 5 years after my diagnosis, I’m doing well.

I have a check-up and a cystoscopy every 3 months, just to see how things are. And I have blood tests and scans done once a year for the same reason. It means going through a couple of minutes of discomfort every few months, but I don’t mind.

It’s worth it, especially if it’s helping keep me cancer-free.

I’m so grateful to have been given the opportunity to join a clinical trial. I truly believe it’s what’s allowed me to see my grandson Tommy grow up.

He’s my little mate. We do everything together. I love taking him to the woods to show him the wildlife and to watch the birds flying around.

But if it wasn’t for research, I might not have got to see him at all.

Right now, things are good. I can look forward to the future and to spending more time with my family and little Tommy. And I truly think that’s thanks to research.

Tommy



from Cancer Research UK – Science blog http://ift.tt/2xvjghQ

Tommy Brennan, 65, is from Merseyside. He and his wife Barbara have two sons, and a three-year-old grandson, also called Tommy.

Here, Tommy senior tells his story of being diagnosed with cancer and joining a clinical trial, which he also shared as part of our Annual Review.

It was March 2012 when I first noticed some blood in my pee. I decided to go to the doctor the next day to get checked out. He did some tests and decided to send me to the hospital for a scan and a cystoscopy – that’s where they use a camera to look at your bladder. It sounds painful, but it’s actually not too bad. I’ve had around 16 of them now!

Even after being referred to the hospital I didn’t think it was anything serious. I thought it might be an infection or something. But unfortunately it wasn’t. The tests showed that I had a tumour in my bladder.

The first thing I thought was: ‘what’?! I was terrified to begin with, but then I decided I had to just get on with it.

My treatment involved chemotherapy as well as surgery to remove the tumour. But the cancer had spread into the muscle tissue, so it was worse than they first thought.

The doctor gave me two options. One was to have very complicated surgery to remove the whole of my bladder and reconstruct it from the bowel. I decided I definitely didn’t want that.

The other was to join a Cancer Research UK-funded clinical trial. Even though the doctor said I should take some time to think about it I decided within around 10 seconds that I wanted to join.

‘I was really well taken care of’

The trial was called TUXEDO and it involved having chemotherapy every week, along with radiotherapy 5 days a week for 7 weeks.

Being close to research made me realise just how much things have progressed.

Tommy Brennan

Before I joined I was told about the long list of possible side effects. That made me panic a little and I was a bit nervous. But I was lucky enough not to experience any of them.

I did put on a bit of weight in the beginning because I was taking steroids, but thankfully I didn’t have to take these for too long.

I was really well taken care of when I was on the trial. All the staff at the hospital were brilliant – from the receptionists through to the nurses, radiologists and doctors. Everyone was fantastic.

On top of that, the clinical trial nurses were really knowledgeable and reassuring, and they put me completely at ease. Without them and my consultant, Dr Hussain, I don’t know where I’d be.

When I finished having my treatment on the trial I had to wait about 3 months before the doctors could tell me whether it had worked.

It was April 2013 when Dr Hussain told me the good news that the treatment had been successful and that my cancer was gone.

I was over the moon.

‘Without clinical trials things would just stand still’

I have to admit that when I joined the trial I was thinking more about myself than anything else. But now I look back and I’m so glad I did something that could potentially help others in the future. And that could help science and cancer medicine move forward.

I knew nothing about clinical trials before I joined one. Now I realise how important they are. They’re needed to test new treatments, new drugs and new drug combinations. Without them we wouldn’t be able to make any progress; things would just stand still.

Being close to research made me realise just how much things have progressed. The advances in technology have been amazing and mean that even though I’ve been in an operating theatre 4 times, there’s not a scar on my body to show for it.

I know it’s not the same for everyone and some people do have scars after surgery. But in my case I’m lucky enough to not have any visible signs of the operations I’ve had.

Five years after his cancer diagnosis, Tommy is doing well.

I got a lot out of being on a clinical trial. Obviously there’s the fact that the treatment worked and my bladder didn’t have to be removed, which was great.

But on top of this, one of the main things I got out of being on the trial was the courage to be more open, and to talk about my cancer experience.

When I was diagnosed, I didn’t want every Tom, Dick and Harry knowing my business so I didn’t talk about it.

But a few months after my diagnosis the local radio station asked me to talk about my experience of being on a trial. And the local newspaper asked me to share my story too.

I decided to do them both.

I changed my mind because I know some people shy away from joining clinical trials and I wanted them to know it can be a really positive thing to take part in one. And I wanted people to know that joining a trial has the potential to help you right away, and many more people in the future.

‘If it wasn’t for research, I might not have got to see my grandson’

I’m delighted to say that 5 years after my diagnosis, I’m doing well.

I have a check-up and a cystoscopy every 3 months, just to see how things are. And I have blood tests and scans done once a year for the same reason. It means going through a couple of minutes of discomfort every few months, but I don’t mind.

It’s worth it, especially if it’s helping keep me cancer-free.

I’m so grateful to have been given the opportunity to join a clinical trial. I truly believe it’s what’s allowed me to see my grandson Tommy grow up.

He’s my little mate. We do everything together. I love taking him to the woods to show him the wildlife and to watch the birds flying around.

But if it wasn’t for research, I might not have got to see him at all.

Right now, things are good. I can look forward to the future and to spending more time with my family and little Tommy. And I truly think that’s thanks to research.

Tommy



from Cancer Research UK – Science blog http://ift.tt/2xvjghQ

Crop circles seen from space

This astronaut photograph was acquired on October 6, 2016. Image via NASA.

Here’s something our agrarian ancestors might have dearly loved to see. It’s an image of crop circles – circular farming patterns – in Sharq El Owainat in southwest Egypt, captured by an astronaut aboard the International Space Station (ISS). NASA Earth Observatory, which published this image on September 18, 2017 wrote:

The remote agricultural outpost in the Sahara Desert lies approximately 290 kilometers (180 miles) from the nearest city and 210 kilometers (130 miles) from the Toshka lakes.

The Nubian Sandstone Aquifer System, buried beneath the sand, allows patches of agriculture to survive in the middle of the desert. The aquifer is the only source of water for Egyptians living away from the Nile River. More than 95 percent of Egypt is uninhabitable desert with an average annual precipitation of 0 millimeters.

The crop circles are a result of center-pivot irrigation, an efficient method for water conservation in agriculture. Groundwater from the Nubian aquifer is drawn up from wells in the center of the circles, and it is sprayed or dripped out of long, rotating pipes that pivot around the center.

Most of the crops pictured here are likely potatoes (darker green circles), wheat (lighter brown circles), or medicinal and aromatic plants such as chamomile. The light, tan-colored crop circles likely have undergone controlled burning to remove excess plant matter and essentially clean up the land for the next crop. Catering to the populace of the New Valley Governate, these crops are transported on a desert road that leads to Abu Simbel (about 200 miles to the east), Dakhla Oasis (200 miles north), and the Sharq El Owainat Airport.

Bottom line: ISS image of crop circles in Egypt, via NASA Earth Observatory



from EarthSky http://ift.tt/2wRGWNS

This astronaut photograph was acquired on October 6, 2016. Image via NASA.

Here’s something our agrarian ancestors might have dearly loved to see. It’s an image of crop circles – circular farming patterns – in Sharq El Owainat in southwest Egypt, captured by an astronaut aboard the International Space Station (ISS). NASA Earth Observatory, which published this image on September 18, 2017 wrote:

The remote agricultural outpost in the Sahara Desert lies approximately 290 kilometers (180 miles) from the nearest city and 210 kilometers (130 miles) from the Toshka lakes.

The Nubian Sandstone Aquifer System, buried beneath the sand, allows patches of agriculture to survive in the middle of the desert. The aquifer is the only source of water for Egyptians living away from the Nile River. More than 95 percent of Egypt is uninhabitable desert with an average annual precipitation of 0 millimeters.

The crop circles are a result of center-pivot irrigation, an efficient method for water conservation in agriculture. Groundwater from the Nubian aquifer is drawn up from wells in the center of the circles, and it is sprayed or dripped out of long, rotating pipes that pivot around the center.

Most of the crops pictured here are likely potatoes (darker green circles), wheat (lighter brown circles), or medicinal and aromatic plants such as chamomile. The light, tan-colored crop circles likely have undergone controlled burning to remove excess plant matter and essentially clean up the land for the next crop. Catering to the populace of the New Valley Governate, these crops are transported on a desert road that leads to Abu Simbel (about 200 miles to the east), Dakhla Oasis (200 miles north), and the Sharq El Owainat Airport.

Bottom line: ISS image of crop circles in Egypt, via NASA Earth Observatory



from EarthSky http://ift.tt/2wRGWNS

Air Force “Spins” a Yarn, Finds New Power Source

Scientists explore use of twistron yarns to monitor respiration and provide energy source.

from http://ift.tt/2fODwkl
Scientists explore use of twistron yarns to monitor respiration and provide energy source.

from http://ift.tt/2fODwkl